Coultreon Biopharma

Transforming lives with groundbreaking treatments

Leuven, United States · Founded 2025 · $125.0M raised

Headquarters
Leuven
Employees
11–50
Founded
2025
Business Model
B2B
Total Funding
$125.0M
Last Round
$125.0M Series AApr 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Coultreon Biopharma (formerly Onco3R Therapeutics) is a Leuven, Belgium-based clinical-stage biotech founded in 2025 developing precision medicines for autoimmune and inflammatory diseases. Its lead asset COL-5671 is a selective SIK3 inhibitor that completed Phase 1 with favorable safety and pharmacokinetic data, targeting ulcerative colitis and other immune-mediated conditions with a once-daily oral therapy.

Summary

Coultreon Biopharma is a Biotech company based in Leuven, United States, founded in 2025. It has raised $125.0M in total across 1 round, most recently a $125.0M Series A round in Apr 2026. Investors include Sofinnova Investments, Forbion Capital Partners and Galapagos.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2026
$125.0M

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Coultreon Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/coultreon-biopharma"><img src="https://indexed.vc/api/badge/company/coultreon-biopharma" alt="Coultreon Biopharma on Indexed.vc" width="260" height="76" /></a>